These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37052411)

  • 1. The epidemiology and psychological comorbidity of disorders of gut-brain interaction in Australia: Results from the Rome Foundation Global Epidemiology Study.
    Knowles SR; Apputhurai P; Palsson OS; Bangdiwala S; Sperber AD; Mikocka-Walus A
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14594. PubMed ID: 37052411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and description of disorders of gut-brain interaction in Spain according to the results of the Rome Foundation Global Epidemiology Study.
    Flores-Arriaga J; Aso MC; Izagirre A; Sperber AD; Palsson OS; Bangdiwala SI; Lanas Á; Bujanda L; Lobo B; Alonso-Cotoner C; Sánchez-Pla Á; Santos J
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14582. PubMed ID: 37010843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of disorders of Gut-Brain interaction in Israel: Results from the Rome Foundation global epidemiology study.
    Sperber AD; Freud T; Abu-Freha N; Shibli F; Brun R; Bangdiwala SI; Palsson OS; Dickman R
    Neurogastroenterol Motil; 2022 Aug; 34(8):e14323. PubMed ID: 35072332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epidemiology and impact of disorders of gut-brain interaction in Canada: Results from the Rome Foundation Global Epidemiologic Study.
    Rodrigues DM; Poitras P; Day AG; Sperber AD; Palsson O; Bangdiwala SI; Vanner SJ
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14585. PubMed ID: 36989173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Greater Overlap of Rome IV Disorders of Gut-Brain Interactions Leads to Increased Disease Severity and Poorer Quality of Life.
    Sperber AD; Freud T; Aziz I; Palsson OS; Drossman DA; Dumitrascu DL; Fang X; Fukudo S; Ghoshal UC; Kellow J; Khatun R; Okeke E; Quigley EMM; Schmulson M; Simren M; Tack J; Whitehead WE; Whorwell P; Bangdiwala SI
    Clin Gastroenterol Hepatol; 2022 May; 20(5):e945-e956. PubMed ID: 34052391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and Burden of Disorders of Gut-Brain Interaction in Romania: A Subgroup Analysis of the Rome Foundation Global Epidemiology Study.
    Dumitrascu DL; Freud T; Ismaiel A; Bangdiwala SI; Palsson OS; Sperber AD
    J Gastrointestin Liver Dis; 2022 Sep; 31(3):273-282. PubMed ID: 36004415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative Impact of Disorders of Gut-Brain Interaction on Health-Related Quality of Life: Results From the Rome Foundation Global Epidemiology Survey.
    Knowles SR; Skvarc D; Ford AC; Palsson OS; Bangdiwala SI; Sperber AD; Mikocka-Walus A
    Gastroenterology; 2023 Apr; 164(4):655-668.e10. PubMed ID: 36565940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of disorders of gut-brain interaction in Western Europe and Asia based on the Rome foundation global epidemiology study.
    Hreinsson JP; Wong RKM; Tack J; Whorwell P; Benninga MA; Andresen V; Bonaz B; Choi SC; Corazziari ES; Santos J; Fukudo S; Kanazawa M; Fang X; Bangdiwala SI; Sperber AD; Palsson OS; Simrén M
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14566. PubMed ID: 36961016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of disorders of gut-brain interaction in Belgium and differences between two language groups: Results from the Rome foundation global epidemiology study.
    Broeders B; Devolder E; Jones M; Simrén M; Bangdiwala SI; Sperber AD; Palsson OS; Tack J
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14588. PubMed ID: 37018388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The national prevalence of disorders of gut brain interaction in the United Kingdom in comparison to their worldwide prevalence: Results from the Rome foundation global epidemiology study.
    Jaafari H; Houghton LA; West RM; Agrawal A; Aziz I; Black CJ; Corsetti M; Shuweihdi F; Eugenicos M; Paine PA; Ford AC; Whorwell PJ; Bangdiwala SI; Palsson OS; Sperber AD; Vasant DH
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14574. PubMed ID: 37018424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of disorders of gut-brain interaction in the Japanese population in the Rome Foundation Global Epidemiological Study.
    Fukudo S; Nakaya K; Muratsubaki T; Nakaya N; Hozawa A; Bangdiwala SI; Palsson OS; Sperber AD; Kanazawa M
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14581. PubMed ID: 37093785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex- and gender-related differences in the prevalence and burden of disorders of gut-brain interaction in Poland.
    Mulak A; Freud T; Waluga M; Bangdiwala SI; Palsson OS; Sperber AD
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14568. PubMed ID: 36989186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the epidemiology of disorders of gut-brain interaction in four Latin American countries: Results of The Rome Foundation Global Epidemiology Study.
    Schmulson MJ; Puentes-Leal GA; Bustos-Fernández L; Francisconi C; Hani A; López-Colombo A; Palsson OS; Bangdiwala SI; Sperber AD
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14569. PubMed ID: 36989176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and associated factors of disorders of gut-brain interaction in the United States: Comparison of two nationwide Internet surveys.
    Palsson OS; Sperber AD; Bangdiwala S; Whitehead WE
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14564. PubMed ID: 36961084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Work productivity and activity impairment in disorders of gut-brain interaction: Data from the Rome Foundation Global Epidemiology Study.
    Frändemark Å; Törnblom H; Hreinsson JP; Andresen V; Benninga MA; Corazziari ES; Fukudo S; Mulak A; Santos J; Sperber AD; Bangdiwala SI; Palsson OS; Simrén M
    United European Gastroenterol J; 2023 Jul; 11(6):503-513. PubMed ID: 37332146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparisons of the Rome III and Rome IV criteria for diagnosis of irritable bowel syndrome in Indian and Bangladeshi communities and internal shifts in the diagnostic categories of bowel disorders of gut-brain interactions.
    Ghoshal UC; Rahman MM; Pratap N; Misra A; Sarker SA; Hasan M; Bangdiwala SI; Palsson OS; Sperber AD
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14579. PubMed ID: 37010834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global patterns of prescription pain medication usage in disorders of gut-brain interactions.
    Luo Y; Camey SA; Bangdiwala SI; Palsson OS; Sperber AD; Keefer LA
    Neurogastroenterol Motil; 2023 Jan; 35(1):e14457. PubMed ID: 36111642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disorders of Gut-brain Interaction on the US-Mexico Border: A Survey Using Rome IV Criteria.
    Bashashati M; Schmulson MJ; Sarosiek I; Robles A; Casner N; Espino K; Elhanafi SE; Zuckerman MJ
    J Clin Gastroenterol; 2024 Apr; 58(4):330-336. PubMed ID: 37267460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased psychological distress and somatization in patients with irritable bowel syndrome compared with functional diarrhea or functional constipation, based on Rome IV criteria.
    Shiha MG; Asghar Z; Thoufeeq M; Kurien M; Ball AJ; Rej A; Tai FWD; Afify S; Aziz I
    Neurogastroenterol Motil; 2021 Oct; 33(10):e14121. PubMed ID: 33719130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence and burden of Rome IV bowel disorders of gut brain interaction in patients with non-alcoholic fatty liver disease: a cross-sectional study.
    Purssell H; Bennett L; Street O; Hanley KP; Hanley N; Vasant DH; Athwal VS
    Sci Rep; 2023 May; 13(1):8769. PubMed ID: 37253969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.